Cargando…

Life-long diseases need life-long treatment: long-term safety of ciclosporin in canine atopic dermatitis

Ciclosporin (Atopica; Novartis Animal Health) has been licensed for canine atopic dermatitis (AD) since 2002. Adverse events (AEs) have been reported in 55 per cent of 759 dogs in 15 clinical trials, but are rare in pharmacovigilance data (71.81 AEs/million capsules sold). Gastrointestinal reactions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nuttall, Tim, Reece, Douglas, Roberts, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995266/ https://www.ncbi.nlm.nih.gov/pubmed/24682696 http://dx.doi.org/10.1136/vr.102471

Ejemplares similares

The long‐term safety of topical corticosteroids in atopic dermatitis: A systematic review
por: Harvey, Jane, et al.
Publicado: (2023)

The Long-Term Safety and Quality of Life Effects of Oats in Dermatitis Herpetiformis
por: Alakoski, Anna, et al.
Publicado: (2020)

The long-term efficacy of heliotherapy in ameliorating disease severity and improving the quality of life in patients with atopic dermatitis
por: Terzić, Zoran, et al.
Publicado: (2023)

Ciclosporin in canine dermatology: a decade of comfort
por: DeBoer, Douglas J.
Publicado: (2014)

Long-term control of atopic dermatitis with platelet-rich plasma
por: Vafaei-Nodeh, Saba, et al.
Publicado: (2020)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
por: MIYAMOTO, Shoko, et al.
Publicado: (2022)

A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs
por: Little, Peter R, et al.
Publicado: (2015)

Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)
por: Olivry, Thierry, et al.
Publicado: (2015)

Identifying biomarkers of treatment response to ciclosporin in atopic dermatitis through multiomic predictive modelling: DERMATOMICS study protocol
por: Marín-Candón, Alicia, et al.
Publicado: (2023)

Real-World Experience of Long-Term Dupilumab Treatment for Atopic Dermatitis in Korea
por: Lee, Dong Hun, et al.
Publicado: (2022)

Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients
por: Wyrzykowska, Nina, et al.
Publicado: (2015)

Emollients “Plus” are Beneficial in Both the Short and Long Term in Mild Atopic Dermatitis
por: Cestari, Silmara, et al.
Publicado: (2023)

Acute Kidney Injury Due to Interaction of Methyl-1-testosterone with Ciclosporin Metabolism in a Patient with Severe Atopic Dermatitis
por: Al-Niaimi, Firas, et al.
Publicado: (2013)

Drug survival of systemic immunosuppressive treatments for atopic dermatitis in a long-term pediatric cohort
por: Elsgaard, Stine, et al.
Publicado: (2021)

Long-term Efficacy of Intravenous Immunoglobulin Therapy for Moderate to Severe Childhood Atopic Dermatitis
por: Jee, Sue-Jung, et al.
Publicado: (2011)

A 52 weeks dupilumab treatment for moderate to severe atopic dermatitis in Korea: long-term efficacy and safety in real world
por: Jang, Dong Hyek, et al.
Publicado: (2021)

Long‐term safety and efficacy of delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with atopic dermatitis
por: Nakagawa, Hidemi, et al.
Publicado: (2019)

Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review
por: Ayen-Rodríguez, Angela, et al.
Publicado: (2022)

Glucocorticosteroids and ciclosporin do not significantly impact canine cutaneous microbiota
por: Widmer, Giovanni, et al.
Publicado: (2018)

Topical treatment with SPHINGOLIPIDS and GLYCOSAMINOGLYCANS for canine atopic dermatitis
por: Marsella, Rosanna, et al.
Publicado: (2020)

Treatment of atopic dermatitis with pimecrolimus – impact on quality of life
por: Lee, Hae-Hyuk, et al.
Publicado: (2007)

Systematic review of published trials: long-term safety of topical corticosteroids and topical calcineurin inhibitors in pediatric patients with atopic dermatitis
por: Siegfried, Elaine C., et al.
Publicado: (2016)

Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis
por: Geng, Bob, et al.
Publicado: (2021)

Quality of life in infants with atopic dermatitis and their families
por: Djurović, Milena Ražnatović, et al.
Publicado: (2020)

Supplementation with long chain polyunsaturated fatty acids in treatment of atopic dermatitis in children
por: Kaczmarski, Maciej, et al.
Publicado: (2013)

Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up
por: Straub, Morgane, et al.
Publicado: (2016)

Disseminated Mycobacterium avium infection in a cat on long-term ciclosporin therapy and potential latent infection of an in-contact cat
por: Webster, Jade, et al.
Publicado: (2022)

Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives
por: Nahm, Dong-Ho
Publicado: (2023)

Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis
por: Geng, Bob, et al.
Publicado: (2021)

Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation
por: Chiricozzi, Andrea, et al.
Publicado: (2023)

Canine atopic dermatitis: Role of luteolin as new natural treatment
por: Gugliandolo, Enrico, et al.
Publicado: (2020)

Educational intervention and atopic dermatitis: impact on quality of life and treatment
por: Muzzolon, Mariana, et al.
Publicado: (2021)

Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
por: ROGNER, Danielle, et al.
Publicado: (2022)

Canine atopic dermatitis attenuated by mesenchymal stem cells
por: de Oliveira Ramos, Fernanda, et al.
Publicado: (2020)

Cannabinoid receptors in the inflammatory cells of canine atopic dermatitis
por: Chiocchetti, Roberto, et al.
Publicado: (2022)

341 Quality of Life in Pediatric Patients with Atopic Dermatitis
por: Campos, Xiomara Lopez
Publicado: (2012)

Quality of Life and Psychological Impact in Patients with Atopic Dermatitis
por: Talamonti, Marina, et al.
Publicado: (2021)

Quality of life, long-term survivors and long-term outcome from the ABC-02 study
por: Bridgewater, John, et al.
Publicado: (2016)

Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants
por: Luger, Thomas, et al.
Publicado: (2015)

Quality of life in atopic dermatitis in Asian countries: a systematic review
por: Huang, Jinghui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_si2ohjh4269723h0kvcpvk2ius